Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Taste and smell training offers hope for chemo patients

NCT ID NCT04716153

Symptom relief Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a sensory rehabilitation program for people who lost their sense of smell or taste after chemotherapy for blood cancers like multiple myeloma or lymphoma. The program involved exercises to retrain the nose and tongue. Only 5 people enrolled before the study ended early, so results are limited. The goal was to improve quality of life and nutrition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

5 people

The number who actually took part.

Started

Jun 2021

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and ≤ 75 years old * Patient with olfactory or gustatory disorders * Patient who has completed chemotherapy for haematological cancer Exclusion Criteria: * Eating disorder known prior to anti-cancer treatment, bulimic, anorexic or binge eating disorder (DSM-V criteria) * Refusal to sign the free and informed consent * Hypersensitivity to one of the components of liposomal sprays (Liposaliva® or liponasal®) * COVID + patient in the previous 3 months * Performance status ECOG 3 or 4 * Patient included in another clinical trial modifying taste / olfaction * Artificial nutrition post-chemotherapy * Known food allergies * Having a reading level in French that may interfere with a good understanding of the protocol and the questionnaires * Presenting visual or hearing deficits uncorrected to normal and which may affect the proper completion of the questionnaires * Patient under curatorship or tutorship. * Patient deprived of liberty * Pregnant or breastfeeding patient * Not be affiliated with a French social security scheme or beneficiary of such a scheme

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Haematological cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Anosmia hematopoietic and lymphoid cell neoplasm lymphoma plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Haematological cancer Lymphoma Multiple myeloma Olfactivo-gustatory disorder

Contacts and locations

Locations

  • Hematology Department, University Hospital Center

    Montpellier, 34 295, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.